share_log

Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

SEC announcement ·  Mar 15 04:08
Summary by Futu AI
RedHill Biopharma Ltd., a specialty biopharmaceutical company, has received a notification from the Nasdaq Listings Qualifications Department on March 11, 2024, indicating that the company's American Depositary Shares (ADSs) have been trading below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market for the past thirty consecutive business days. This notice does not immediately affect the listing or trading of RedHill's ADSs. The company has until September 9, 2024, to regain compliance with the minimum bid price requirement, as per Nasdaq Listing Rule 5810(c)(3)(A). RedHill's ADSs will continue to trade on The Nasdaq Capital Market, and its operations remain unaffected. RedHill is considering options to address the deficiency and may be eligible for an additional 180-day compliance period if necessary conditions are met.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, has received a notification from the Nasdaq Listings Qualifications Department on March 11, 2024, indicating that the company's American Depositary Shares (ADSs) have been trading below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market for the past thirty consecutive business days. This notice does not immediately affect the listing or trading of RedHill's ADSs. The company has until September 9, 2024, to regain compliance with the minimum bid price requirement, as per Nasdaq Listing Rule 5810(c)(3)(A). RedHill's ADSs will continue to trade on The Nasdaq Capital Market, and its operations remain unaffected. RedHill is considering options to address the deficiency and may be eligible for an additional 180-day compliance period if necessary conditions are met.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.